Literature DB >> 24344913

RD Lawrence lecture 2013. Stratified approaches to the management of diabetes.

E Pearson1.   

Abstract

A stratified approach to medicine aims to identify subgroups of patients who should be managed differently from others. Diabetes is a condition that offers considerable potential for stratification, in areas of drug response, complication risk and rate of progression amongst others. Approaches to stratification can be simple, using clinical phenotyping, or more complex involving genomic and other '-omic' technologies. In this review, I will highlight the utility of measuring endogenous insulin production to aid in diagnosis and appropriate treatment; outline key advances in monogenic diabetes where determining genetic aetiology can result in dramatic changes in treatment, and describe the developments in the field of pharmacogenetics in Type 2 diabetes.
© 2014 The Author. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24344913     DOI: 10.1111/dme.12391

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  New approaches beyond genetics: towards precision medicine in diabetes.

Authors:  Leif Groop
Journal:  Diabetologia       Date:  2016-10-08       Impact factor: 10.122

Review 2.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

3.  Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study.

Authors:  Peter Eibich; Amelia Green; Andrew T Hattersley; Christopher Jennison; Mike Lonergan; Ewan R Pearson; Alastair M Gray
Journal:  Diabetes Ther       Date:  2017-09-06       Impact factor: 2.945

Review 4.  Precision medicine in diabetes prevention, classification and management.

Authors:  Fangying Xie; Juliana Cn Chan; Ronald Cw Ma
Journal:  J Diabetes Investig       Date:  2018-04-25       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.